₨ Official source-observed price
PKR 110.89
1's
PKR 110.89 / vial/unit
✓ Official DRAP price source observed · Source checked 2026-09-23
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 110.89/ vial/unit
Price position5% above medianvs like-for-like peer median
Peer comparators67current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Cefotaxime
- Therapeutic area
- Anti-infectives
- Drug class
- Third-generation cephalosporins
- ATC
- J01DD
- Strength
- 250 mg
- Dosage form
- Injection
- Pack
- 1's
- Registration no.
- 033795
- Price record verified
- 2026-08-07
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
LINZ PHARMACEUTICALS (PVT) LTD.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 110.89 | 2026-07-27 | 2026-08-07 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
ADOXIME cefotaxamine 500 mgAdamjee Pharmaceuticals (Pvt) Ltd · PKR 158.97ADOXIME cefotaxamine 250 mgAdamjee Pharmaceuticals (Pvt) Ltd · PKR 105.46ADOXIME cefotaxamine 1 gAdamjee Pharmaceuticals (Pvt) Ltd · PKR 285.88Algixim 250 mgEpharm Laboratories · PKR 97.08Algixim 500 mgEpharm Laboratories · PKR 168.48Algixim 1 gEpharm Laboratories · PKR 297.32Amzax 2 gAMROS PHARMACEUTICALS · PKR 430.25Amzax 500 mgAMROS PHARMACEUTICALS · PKR 158.94
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 033795MedInfoBase. (2026). Taxomic 250 mg Injection (1's), LINZ PHARMACEUTICALS (PVT) LTD. — registration and price record [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/brand/taxomic-250-mg-033795-1s-linz-pharmaceuticals-pvt-ltd/ Data observed 7 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 033795.
MedInfoBase. Taxomic 250 mg Injection (1's), LINZ PHARMACEUTICALS (PVT) LTD. — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 23]. Available from: https://medinfobase.com/brand/taxomic-250-mg-033795-1s-linz-pharmaceuticals-pvt-ltd/ Data observed 7 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 033795.
MedInfoBase (2026) Taxomic 250 mg Injection (1's), LINZ PHARMACEUTICALS (PVT) LTD. — registration and price record. Available at: https://medinfobase.com/brand/taxomic-250-mg-033795-1s-linz-pharmaceuticals-pvt-ltd/ (Accessed: 23 September 2026).
"Taxomic 250 mg Injection (1's), LINZ PHARMACEUTICALS (PVT) LTD. — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/taxomic-250-mg-033795-1s-linz-pharmaceuticals-pvt-ltd/. Accessed 23 Sep 2026.
MedInfoBase. 2026. "Taxomic 250 mg Injection (1's), LINZ PHARMACEUTICALS (PVT) LTD. — registration and price record." Accessed September 23, 2026. https://medinfobase.com/brand/taxomic-250-mg-033795-1s-linz-pharmaceuticals-pvt-ltd/.
Price and registration data on this page were observed on 7 August 2026. Records change over time, so please cite the observation date alongside the access date.